News and Updates


NEW! Data2Evidence Cohort Query Tool Training – May 12 and 26 from 9:00-10:00 am EST – REGISTRATION NOW OPEN!

 
We’re excited to invite you to explore Data2Evidence, a new tool designed to support and enhance clinical cohort discovery and analysis workflows.
We will be holding in-person and virtual Data2Evidence training sessions on May 12, and May 26, 2026, from 9:00-10:00 EST. You can register for these sessions as follows:
 
Data2Evidence can be accessed at d2e.airms.mssm.edu by all existing Mount Sinai and Icahn School of Medicine users on site or via VPN. It does not require separate registration currently.
 
For additional information about how Data2Evidence may benefit your research visit our website: https://labs.icahn.mssm.edu/minervalab/d2e-data2evidence-cohort-query-tool/

 


Appointment of Mr. Herve DiBello as Director of Technology, AI-Ready Mount Sinai (AIR·MS), and Dr. Ashwin Sawant as Medical Director, AI-Ready Mount Sinai (AIR·MS).

March 2026

We are pleased to announce that Mr. Herve DiBello has been appointed as Director of Technology, AI-Ready Mount Sinai (AIR·MS), and Dr. Ashwin Sawant has been appointed as Medical Director, AI-Ready Mount Sinai (AIR·MS).

Herve DiBello brings 30 years of experience in the technology sector as a senior data engineer. Prior to joining Mount Sinai, he spent a significant portion of his IT career as a consultant for Systems, Applications, and Products in Data Processing (SAP), where he worked across various technologies and industries, focusing exclusively on healthcare solutions in recent years. In his new role, Mr. DiBello will lead an engineering team in bringing new data modalities to AIR·MS and serve as chief technical architect for new technology solutions integrated into the platform. His expertise will be pivotal in advancing the technological capabilities of AIR·MS and ensuring its seamless integration with healthcare research initiatives.

Dr. Ashwin Sawant is a practicing internist and informaticist with deep expertise at the intersection of clinical care, data, and technology. In this role, he will work closely with researchers and clinicians to understand their scientific, clinical, and operational needs, and to ensure those needs are effectively supported by the AI-enabled platform. In addition, Dr. Sawant will partner with the engineering team led by Mr. DiBello to guide the integration of diverse data modalities, helping ensure that the platform is clinically grounded, scalable, and aligned with real-world use cases.
 
Please join us in welcoming Mr. DiBello and Dr. Sawant in their new roles. We look forward to their leadership
and perspective as they spearhead the next phase of the AIR·MS platform.
 
 

 


 

ALERT – MARK YOUR CALENDARS!

Digital Health Partnership Workshop and Datathon/Hackathon New York 2026

Mark your calendars for May 4–8, 2026: The Digital Health Partnership is coming to New York at the Mount Sinai Health System.

Stay tuned for more details!

 


 

January 2026

Artificial Intelligence – Ready Mount Sinai (AIR·MS). One Platform. Rapid Answers. Improved Research.

Research flourishes when ideas flow naturally into evidence, and each discovery builds on the last. AIR·MS has been created to bring this vision to life —a platform where data, analysis, and collaboration converge effortlessly, providing Mount Sinai with a single environment in which complex research can be conducted with clarity, efficiency, and speed.

At its core, AIR·MS combines clinical records, imaging, signals, and other research data in one unified system designed for both scale and performance. Large datasets reside in memory, allowing analyses to be performed interactively and iteratively. By supporting both relational and graph-based approaches, AIR·MS captures the richness of clinical and biological relationships, enabling researchers to explore questions in a manner that more closely reflects the real world.

 

AIR·MS Champions


 

Lothar H. Wieler, DVM

“Great solutions come with great minds, candor, integrity, and sincere teamwork that make them come into living. Through collaborative measures AIR·MS got momentum, and with our trusted partnership we will leverage this platform based on high quality data to generate excellent information, serving public health and health care.”

Dr. Ben Illigens

“Too often, biomedical research is slowed by fragmented data, complex access, and disconnected tools. AIR·MS addresses this challenge by making one of the world’s richest clinical datasets accessible in a high-performance, AI-ready environment. We´re now on track in onboarding 1,000 new users in 2026 – this marks a turning point in how we scale real-world evidence and empower researchers with everything they need on one platform to turn data into impact.”

Girish N. Nadkarni, MD, MPH

“The success of AIR·MS is grounded in teamwork. Advancing AI in real-world clinical settings requires clinicians, data scientists, engineers, and operational leaders working as one. It’s the collective effort, aligned around clear goals, that allows us to move from ideas to impact.”


 

AIR·MS Researcher Stories: Real Research. Real Impact.

To grow the AIR·MS (AI- Ready Mount Sinai) research community, we are launching the AIR·MS Researcher Stories campaign – putting researchers and their real-world use cases at the center.

We invite all AIR·MS users to share how they use the platform to access multimodal clinical data and advance AI-driven biomedical research. Selected stories will be featured across our website, newsletter, and social channels – strengthening peer learning and community visibility.

As a small thank-you, the first 50 researchers who share their story will receive an AIR·MS Researcher Trophy: a limited-edition mug celebrating community contribution and innovation.

With a target of 1,000 AIR·MS users, we believe real stories from real researchers are the most powerful way to grow – together.

 


 

Mount Sinai User Requirement Workshop – HPI Bachelor students visiting Mount Sinai Health Systems in New York

The eight of you need to go to New York.”
That was what Lothar Wieler said in a meeting about two months ago. We followed that advice – and we are definitely not complaining.

“The eight” turned out to be Charlotte Beurer, Markus Rünzel, Tobias Rademacher, Peer Schild, Simon Kossack, Jan Berndt, Daniel Cermann and Nele Rodenhagen. And so, in January, we suddenly found ourselves in New York City, where our Bachelor project moved from shared documents and video calls to hospital corridors and real conversations.

 

Under the supervision of Lothar Wieler, we are developing a tool that supports Infection Preventionists in gaining a clearer overview of infection chains of specific pathogens especially MRSA. The aim is to turn complex data into something that is actually useful in everyday hospital work – the helping not only to respond to ongoing outbreaks but also to recognize risks early and prevent them.

AIR·MS With New Dataset


 

Uncovering Treatment Resistance in Psychiatry with AIR·MS –Zeinab Soleimani, PhD Candidate, Hasso Plattner Institute


 

Zeinab Soleimani’s research focuses on one of psychiatry’s most pressing challenges: understanding treatment resistance across anxiety, depression, bipolar, and schizophrenia spectrum disorders. These conditions often show overlapping symptoms and highly individual disease trajectories, making personalized treatment decisions difficult.

Using AIR·MS, Zeinab analyzes Electronic Health Records (EHR) and clinical notes from the Mount Sinai Health System to identify patterns of treatment resistance – defined by symptom alleviation, side effects, and patient adherence. Her work combines…